New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, ...

By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...

The global transcatheter mitral valve market is on a strong growth trajectory, with projections estimating a market valuation of USD 1.6 billion by the end of 2024 and an impressive compound annual ...

MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...

Darshin Patel discusses the first-of-its-kind Sapien M3 TMVR system's design, development and lessons for other medical ...

For patients with mitral valve prolapse (MVP) and mitral regurgitation (MR), mitral annular disjunction (MAD) is associated ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

IRVINE, Calif., April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the ...

CHICAGO - Ahead of Mother's Day, a Chicago-area mom and daughter are sharing their story in hopes of encouraging others to ...